Real-life cases, the knowledge, the insight and the strategies for success in the fast-changing NHS environment

EVENT OVERVIEW

“Pharma marketeers need to wake up and smell the coffee”
- senior UK big pharma executive, October 2004

The NHS is undergoing its most rapid period of change – at least as far as pharma sales and marketing managers are concerned. The most worrying thing is that most UK pharma marketers know this themselves, but are find it difficult to to do much more than pay lip service to NHS Changes.

The truth is that these latest developments are fundamental to the future success of UK pharma. This major new two-day conference will assist all UK managers in reformulating and benchmarking their developing strategies.

With the new GMS contract, new pharmacy contract, diversion of funds towards primary care, strengthening of NICE guidance, further introduction of NSFs and a focus on prescribing partnerships, the situation has never been more complex for a UK marketing or sales manager. The industry is forced to become market aligned, rather than product orientated – and this is nothing short of a revolution in patient care. Indeed, there have also never been more opportunities for UK pharma and first-mover-advantage is still up for grabs.

Crucially, it is likely that if you do not embrace these changes - especially in terms of meeting the needs of NHS managers and clinicians – you may well find that you are suddenly facing a shortfall in performance relative to your competitors.

The theme and objective of the conference is to enable pharma companies to focus on producing effective outcomes:

• Outcomes for patients – prevention and cure of chronic disease
• Outcomes for the pharma industry – effective partnerships, greater market share, greater profitability .Outcomes specifically for marketing & the whole clinical development functions to ensure that the evidence is presented in the most appropriate fashion to make the business case
• Outcomes for the wider NHS DOH– meeting of national targets and a healthier UK
• Outcomes for the ABPI –showing how the industry is working in partnership to achieve those national targets
• Outcomes for prescribers – enable doctors and nurses to beat their targets